Blockonomi

Key Highlights
Micron shares climbed 1.2% to $1,028.80 in Tuesday’s premarket session, marking an 18% advance over the last month
DRAM pricing increased 6% month-over-month in July; NAND pricing surged 9%
Fourth-quarter revenue estimates stand at $50.41 billion, a significant jump from last year’s $11.32 billion
Adjusted earnings per share forecasted at $30.89, compared to $2.84 in the prior year period
Wall Street’s consensus price target of $1,295 suggests approximately 27% upside potential
Micron stock showed strength in Tuesday’s premarket hours, trading at $1,028.80 with a 1.2% gain, extending an impressive rally that has delivered 18% returns over the past thirty days. Fresh memory chip pricing statistics appear to be fueling additional investor enthusiasm.
Data from World Semiconductor Trade Statistics reveals that DRAM average selling prices advanced 6% in July compared to June. NAND pricing experienced a more robust 9% increase during the same timeframe. J.P. Morgan’s Harlan Sur highlighted that June figures were also adjusted upward, with both DRAM and NAND sales revised approximately 6% higher.
Given that DRAM represents approximately 75% of Micron’s total revenue mix, these pricing trends carry significant weight as the earnings announcement approaches.
The memory chipmaker will unveil its fiscal fourth-quarter results on September 30. Wall Street consensus calls for quarterly revenue of $50.41 billion, a massive increase from $11.32 billion reported in the comparable year-ago quarter. Adjusted earnings per share are anticipated to reach $30.89, dramatically higher than last year’s $2.84.
This represents extraordinary growth momentum. The company’s third-quarter revenue reached $41.5 billion, representing a 74% sequential increase from Q2 and a staggering 346% year-over-year jump.
Technical Picture Points to Continued Strength
Examining the technical setup, MU has surged from its July trough of $736 to approximately $1,016, delivering close to 40% gains. The shares are maintaining support above the 50-day Exponential Moving Average while trading above both the Ichimoku cloud and Supertrend indicator.
The Relative Strength Index has advanced to 60, marking its strongest level since late June and indicating growing upward momentum. Technical traders are targeting $1,253 as the next significant resistance zone, representing roughly 22% potential appreciation from present levels.
The stock’s performance has also tracked closely with other memory sector players such as SanDisk, Samsung Electronics, and SK Hynix.
Attractive Valuation Compared to Broader Market
Even after the recent rally, Micron’s forward price-to-earnings multiple stands at 13.85. By comparison, the S&P 500 commands approximately 19.9 times forward earnings, while the technology sector trades around 22 times. This valuation discount has attracted analyst attention.
Wall Street’s average price target sits at $1,295, implying about 27% upside from current trading levels.
It’s worth noting that Micron doesn’t capture every dollar of rising chip prices directly in revenue. The company has established long-term supply contracts with key customers, which set pricing ceilings in return for margin stability. Nevertheless, the broader pricing trend clearly works in the company’s favor.
Major clients such as Nvidia, AMD, Google, and Amazon have all delivered robust recent earnings and elevated their forward outlooks, signaling sustained demand for Micron’s memory solutions.
Company management has provided guidance for fourth-quarter revenue exceeding $50 billion, while analysts project full-year revenue reaching $242 billion in the upcoming fiscal year.
The September 30 earnings announcement represents the next critical catalyst for MU shareholders.
The post Micron (MU) Stock Gains Momentum as Memory Chip Prices Surge Before Q4 Earnings appeared first on Blockonomi.

Key Highlights
Shares of Corning surged more than 7% on Tuesday following Verizon’s announcement of a multi-billion dollar partnership extending through 2032.
The agreement calls for Corning to deliver over 80 million miles of advanced optical fiber to Verizon between 2027 and 2032.
This partnership will fuel Verizon’s broadband network expansion and support infrastructure for AI computing applications.
The new contract strengthens a three-decade business relationship between Verizon and Corning.
In 2026 alone, Corning has announced multiple landmark agreements with tech giants including Amazon, Meta, and received significant investment from Nvidia.
Shares of Corning rallied more than 7% to approximately $165 during Tuesday’s trading session after telecommunications giant Verizon announced a substantial multi-year supply partnership with the optical networking specialist.
The arrangement spans a five-year period beginning in 2027 and running through 2032. Through this partnership, Corning will deliver Verizon over 80 million miles of advanced optical fiber products along with comprehensive connectivity solutions.
According to Verizon, this strategic agreement aims to enhance nationwide broadband availability for consumers while simultaneously supporting the infrastructure requirements for generative AI computing systems. The telecommunications company has set ambitious goals of reaching 40 to 50 million broadband passings, encompassing both fiber-to-the-home deployments and connectivity for local businesses.
Kyle Malady, CEO of Verizon, emphasized that this partnership enables the company to “continue building the network of the future at an unprecedented scale.” Malady further noted that Verizon is constructing a unified network architecture that integrates wireless and broadband capabilities while simultaneously serving hyperscale AI providers.
Beyond consumer applications, the fiber network infrastructure will function as critical backbone connectivity linking data centers along major cross-country routes—an essential component of the ongoing AI infrastructure expansion.
Series of Landmark Partnerships
The Verizon agreement represents another milestone in what has been an exceptional year for Corning. Earlier in June, the optical communications leader revealed a multi-billion dollar partnership with Amazon focused on producing optical fiber for data center operations.
During May, Nvidia announced it would invest as much as $3.2 billion in Corning to expand optical networking production capabilities across facilities in Texas and North Carolina.
Earlier in January, Corning secured a substantial $6 billion agreement with Meta Platforms to deliver cabling infrastructure, optical fiber products, and connectivity systems for the social media giant’s data center network.
The latest Verizon partnership extends a business relationship that has spanned three decades. Products included in the agreement feature Corning’s innovative Contour Flow Cable technology, which enables installation of increased fiber capacity through existing underground conduit infrastructure.
Mike O’Day, who serves as Senior Vice President and General Manager at Corning Optical Communications, expressed enthusiasm about expanding the Verizon collaboration, noting the company’s ability to deliver cutting-edge optical solutions that connect AI data centers while simultaneously broadening residential broadband accessibility.
Stock Market Performance
Tuesday’s positive momentum extended beyond Corning to other optical networking companies. Ciena’s shares increased 1.9%, Coherent gained 2.9%, and Lumentum advanced 2%. Verizon’s stock also moved higher, rising approximately 0.8% to reach $50.46.
During late July, Corning reported second-quarter financial results that exceeded Wall Street expectations, although forward guidance fell somewhat short of analyst projections. At that time, CEO Wendell Weeks indicated the company was “entering a new phase of accelerating growth.”
This newly announced Verizon partnership appears to validate that outlook, providing Corning with guaranteed revenue visibility extending several years into the coming decade.
The post Corning (GLW) Stock Surges 7% on Major Verizon Fiber Deal Worth Billions Through 2032 appeared first on Blockonomi.

Key Takeaways
UBS elevated LMT to Buy from Neutral, increasing the price objective to $674 from $581
Firm anticipates 9% compound annual revenue expansion through 2028, powered by missile systems, F-35 support services, CH-53K helicopter, and Trident initiatives
Missile and fire control division expected to deliver 150% revenue expansion between 2025 and 2030
Current valuation shows 15% discount versus S&P 500, which UBS considers unwarranted based on growth trajectory
UBS earnings forecast for 2028 of $39.34 per share exceeds Street consensus by 12%
Shares of Lockheed Martin (LMT) received a positive catalyst Tuesday following UBS upgraded the defense contractor to Buy from Neutral while boosting its price objective to $674 from $581. Shares were changing hands near $525 when the upgrade was issued.
UBS analyst Gavin Parsons presented a bullish investment thesis centered on ramping missile manufacturing, expanding defense expenditures, and diversified revenue sources extending beyond the F-35 fighter jet. The investment bank anticipates approximately 9% compound annual revenue growth extending to 2028.
The missile and fire control segment forms the backbone of this optimistic outlook. UBS anticipates this business unit generating 150% revenue growth spanning 2025 through 2030, with manufacturing volumes across four principal missile platforms expanding over 30% annually before moderating to a sustained, slower pace.
Critical programs propelling this expansion include the PAC-3 interceptor system, Terminal High Altitude Area Defense (THAAD), Precision Strike Missile, and JASSM/LRASM weaponry. Lockheed has secured framework contracts valued at approximately $35 billion for THAAD systems and $59 billion for PAC-3 production.
This demand surge stems from diminished Western munitions inventories, elevated stockpile requirements, and growing international defense investments. UBS characterizes this expansion as a fundamental market transformation rather than a temporary spike.
Additional Growth Drivers
The investment case extends well beyond missile systems. UBS highlighted F-35 support services, the CH-53K heavy transport helicopter, and the Trident submarine-launched ballistic missile program as underestimated growth engines.
The F-35 program represented approximately 27% of Lockheed’s 2025 total revenue. While aircraft manufacturing growth is anticipated to advance gradually, UBS projects accelerated expansion in maintenance operations and technical support as the worldwide fleet expands and demands increased servicing.
Financial Projections
UBS anticipates Lockheed generating revenue of $81.05 billion in 2026, $88.48 billion in 2027, and $96.13 billion in 2028. The 2028 projection exceeds Wall Street consensus estimates by approximately 6%.
Regarding profitability, UBS projects adjusted earnings per share of $30.69 in 2026, $34.50 in 2027, and $39.34 in 2028. That final figure stands 12% above consensus analyst expectations.
Free cash generation may experience temporary compression in 2027 attributed to pension funding obligations, but UBS anticipates robust recovery, climbing from $6.9 billion in 2025 to approximately $9.6 billion by 2030.
The investment bank values LMT at approximately 11.8 times forward-12-month EV/EBITDA, representing a 15% discount compared to the S&P 500. UBS considers this discount unjustified and increased its valuation multiple to reflect enhanced confidence in the company’s expansion potential.
Under an optimistic scenario, UBS projects the stock could reach $870. The bearish case establishes a floor value of $452.
Recent contract awards reinforce the growth narrative. The Pentagon issued Lockheed a $90.2 million modification for the Trident II Life Extension initiative, three Naval contracts totaling $41.8 million, and a $49 million agreement for Target Sight System maintenance services.
A seven-year framework deal with the U.S. Department of War focuses on increased production of THAAD and PAC-3 Missile Segment Enhancement interceptors.
Lockheed concluded trading at $524.48 on September 4.
The post UBS Upgrades Lockheed Martin (LMT) Stock to Buy with $674 Price Target appeared first on Blockonomi.

Key Takeaways
L3Harris secured a monumental $4.7 billion seven-year agreement with Lockheed Martin to manufacture PAC-3 missile propulsion components
This marks the largest PAC-3 propulsion contract award in the company’s history
CalSTRS dramatically expanded its LHX holdings by 27,873% during Q2, now controlling 44.98% ownership valued at $24.34 billion
The company exceeded Q2 expectations with earnings per share of $3.13 versus the anticipated $2.80, while revenue reached $5.88 billion—an 8.4% increase year-over-year
Trading commenced at $256.45 on Tuesday, hovering near the 52-week bottom of $256.05, while analysts maintain a “Moderate Buy” consensus with a $360.45 average target
Defense technology specialist L3Harris Technologies (LHX) has landed a substantial $4.7 billion contract with Lockheed Martin to manufacture propulsion systems for PAC-3 Missile Segment Enhancement interceptors. Trading opened Tuesday at $256.45, positioned just above the 52-week floor of $256.05.
Spanning seven years, this agreement represents the most significant PAC-3 propulsion contract in L3Harris’s corporate history. The company indicates this arrangement supports a broader long-term structure connected to Department of Defense requirements.
The agreement encompasses three critical components: an advanced two-pulse solid rocket motor, the Lethality Enhancer system, and Attitude Control Motors. These represent fundamental building blocks of the MSE interceptor platform.
Currently, the contract remains undefinitized, indicating that final pricing structures and detailed terms continue under negotiation. L3Harris has noted that ultimate outcomes hinge on sustained funding reaching the complete contract ceiling.
To accommodate manufacturing demands, L3Harris initiated construction on two new production facilities at its Camden, Arkansas location in June. These plants are scheduled to commence operations by 2027.
The Camden development represents just one component of a comprehensive manufacturing expansion. L3Harris has established approximately 60 new facilities while adding over one million square feet of production capacity throughout Alabama, Virginia, and Arkansas.
Ken Bedingfield, who leads Missile Solutions at L3Harris, indicated the contract enables continued expansion of PAC-3 propulsion manufacturing capabilities. This represents a logical progression for an organization that has committed substantial resources to this sector over recent years.
Major Institutional Movement
On the investor front, the California State Teachers Retirement System (CalSTRS) executed a remarkable maneuver during Q2, expanding its LHX holdings by an extraordinary 27,873%. The pension fund now controls 83.76 million shares valued at $24.34 billion, representing approximately 45% of the entire company.
Such dramatic institutional commitment draws attention, particularly given the stock’s proximity to 52-week lows. Collectively, institutional investors control 84.76% of L3Harris shares.
Strong Quarterly Results, Lowered Price Targets
L3Harris delivered impressive Q2 financial results. Earnings per share reached $3.13, surpassing the $2.80 consensus estimate by $0.33. Revenue totaled $5.88 billion, representing an 8.4% year-over-year increase and exceeding the $5.81 billion projection.
Management established full-year 2026 EPS guidance between $11.80 and $12.00, while analysts project $11.88 for the complete fiscal year.
Notwithstanding the earnings outperformance, multiple analysts reduced their price objectives. UBS decreased its target from $312 down to $298. Susquehanna adjusted downward from $410 to $350. BNP Paribas Exane moved from $330 to $310.
The analyst consensus continues to reflect a “Moderate Buy” rating with a mean price target of $360.45, substantially exceeding current trading levels.
L3Harris announced a quarterly dividend distribution of $1.25 per share, scheduled for payment on September 18, yielding 1.9% annually. The ex-dividend date occurred on September 4.
The 52-week peak stands at $379.23, positioning the current opening price of $256.45 approximately 48% below that threshold.
The post L3Harris (LHX) Secures Massive $4.7B PAC-3 Missile Deal Amid Stock Decline appeared first on Blockonomi.

Key Highlights
Archer Aviation’s Midnight eVTOL successfully flew a 40+ mile round-trip journey between Hollister and Salinas, California, taking approximately 12 minutes per leg at 125 mph.
Following this achievement, ACHR stock registered a modest 0.35% gain in pre-market hours.
The company conducted over 70 test flights during August and has expansion plans for Northern California, followed by operations in LA, Texas, Florida, and New York.
August saw ACHR surge 24.6% on news of acquiring Boeing’s Wisk Aero, SkyGrid, and Insitu operations.
Analyst consensus rates ACHR as a Strong Buy, with a $11.60 average target price suggesting upside potential exceeding 103%.
On September 8, Archer Aviation’s Midnight aircraft successfully executed a piloted round-trip journey connecting Hollister and Salinas municipal airports in California, marking another milestone in the company’s “No Roads” demonstration tour. Trading at approximately $5.72, ACHR stock showed a minimal 0.35% uptick during pre-market sessions.
The journey spanned over 40 miles with each leg requiring about 12 minutes of flight time. By comparison, the identical route via automobile typically demands 30 to 40 minutes. The Midnight aircraft reached speeds of 125 mph while maintaining a cruising altitude of 3,550 feet.
These demonstration flights are being executed in close collaboration with the Federal Aviation Administration. According to Archer, the tour serves as a critical component in accumulating practical operational expertise before launching its commercial air-taxi operations.
Day trippin’
Midnight flew its first "No Roads" tour route last Friday: a piloted roundtrip between Salinas and Hollister, CA.
12 min each way by air instead of ~40 min by car.
125 mph. 3,550 ft. 40+ miles roundtrip.
Next stops: Monterey, San Martin, San Jose, Oakland, San… pic.twitter.com/bP05jAu52W
— Archer (@flyarcher) September 8, 2026
During August, Archer completed over 70 test flights, which included another piloted round-trip journey connecting Salinas and Monterey. This represents a significant acceleration in flight operations for a company still navigating the FAA certification process.
Nationwide “No Roads” Tour Expansion Underway
The demonstration tour will continue throughout Northern California, with scheduled appearances in Monterey, San Martin, San Jose, Oakland, and San Francisco. Following the California phase, Archer intends to demonstrate flights around Los Angeles before participating in the White House’s eVTOL Integration Pilot Program across Texas, Florida, and New York.
According to CEO Adam Goldstein, the objective centers on operating authentic routes and accumulating operational experience in preparation for the LA28 Olympic Games and the company’s anticipated eVTOL service launch.
However, the subdued pre-market response to ACHR’s latest achievement reveals investor sentiment clearly. Market participants remain focused on critical milestones including FAA certification completion, commercial service launch dates, and actual revenue generation.
August Surge Driven by Boeing Acquisition
During August, ACHR stock soared 24.6%, significantly outperforming both the S&P 500’s 2.6% advance and the Nasdaq’s 3.9% monthly gain. The primary catalyst was the August 10 announcement regarding Archer’s acquisition of three Boeing subsidiaries: Wisk Aero, SkyGrid, and Insitu.
Wisk brings extensive experience with over 1,700 test flights in the eVTOL sector. SkyGrid contributes air-traffic management capabilities and autonomous flight technology. Insitu provides drone manufacturing expertise and associated software platforms.
As part of the transaction structure, Boeing will obtain a 16.5% ownership stake in Archer through newly issued shares. This arrangement results in meaningful dilution for current shareholders, an important consideration for investors.
On the positive side, Insitu currently operates profitably, generating approximately $200 million in annual revenue. This would provide Archer with an immediate revenue stream and enhanced financial profile.
Despite August’s strong performance, ACHR remains down roughly 24% on a year-to-date basis and has declined approximately 1.2% through September thus far.
Six Wall Street analysts have issued ratings on ACHR over the past three months, establishing a Strong Buy consensus rating. The average target price stands at $11.60, representing potential upside of more than 103% from the current trading level of $5.72.
ACHR’s 52-week trading range extends from $4.30 to $14.62, providing perspective on the stock’s current positioning.
The post Archer Aviation (ACHR) Stock: Midnight eVTOL Aircraft Achieves 40-Mile Journey in California appeared first on Blockonomi.

Key Takeaways
A new partnership between Accenture and Google Cloud established the Accenture Gemini Enterprise Business Group for enterprise agentic AI deployment.
The initiative will train as many as 1,000 forward-deployed engineers (FDEs) for on-site client engagement.
Shares of Accenture declined 3% while Google stock dropped 1% during early Tuesday market activity.
This strategy mirrors comparable FDE initiatives from Palantir, OpenAI, Anthropic, Microsoft, and Amazon Web Services.
Prior to this announcement, Accenture maintained approximately 50,000 professionals trained in Google Cloud technologies.
Shares of Accenture (ACN) experienced a 3% decline while Alphabet (GOOGL) fell 1% during early Tuesday trading following the companies’ announcement of a collaborative business division designed to position AI specialists directly within customer organizations.
Named the Accenture Gemini Enterprise Business Group, this new division combines Accenture’s Gemini Enterprise-certified talent, dedicated Google Cloud technical staff, and Accenture’s sector-specific consultants.
The initiative aims to deliver tangible, quantifiable outcomes from agentic AI implementations, moving beyond experimental projects that fail to achieve production scale.
Central to this division are forward-deployed engineers, commonly known as FDEs. These specialized professionals integrate directly within client operations to design, develop, and implement AI solutions from within the organization.
Google Cloud has committed to training up to 1,000 of these embedded engineers. Additionally, a select group of Google Cloud’s internal FDEs will collaborate with premier clients on a restricted engagement basis.
Accenture CEO Julie Sweet articulated the challenge directly: “AI is simple to try and hard to scale, and that’s the moment leaders are in right now.”
Following an Established Industry Pattern
Palantir pioneered the FDE approach, which has subsequently been adopted throughout the technology sector. OpenAI introduced its own professional services division, OpenAI Deployment Co., earlier this year. Anthropic operates its Applied AI division. Both Microsoft and Amazon Web Services have implemented comparable strategies in recent months.
Accenture and Google are effectively entering a competitive landscape that’s already significantly developed.
Google Cloud CEO Thomas Kurian noted that organizations face challenges not only in constructing AI capabilities, but in comprehending how their operational workflows must evolve accordingly.
“There’s a need for experts who can go and do these things for customers,” Kurian said.
Operational Structure of the New Division
Operationally, Accenture positions specialized “pods” within client companies. Each pod comprises FDEs responsible for solution development, working alongside domain specialists, workflow analysts, and data scientists.
A representative engagement involved a pod tasked with automating invoice workflows. Throughout an eight to twelve week period, the team documented existing processes, connected enterprise data sources, and constructed a production-ready agentic AI system, accompanied by a comprehensive deployment strategy for organization-wide implementation.
After the FDE contingent completes their assignment, additional Accenture personnel assume responsibility for enterprise-wide deployment activities.
Before this announcement, Accenture maintained approximately 50,000 professionals with Google Cloud capabilities. This new division establishes an additional tier of specialized, certified competency beyond that foundation.
Sweet emphasized that Accenture’s extensive enterprise implementation experience provides a strategic advantage: “You have to know how you actually deploy a system in a big company.”
While Accenture and Google Cloud acknowledged that the new division represents a significant capital commitment, they chose not to disclose precise financial figures.
Both ACN and GOOGL shares continued trading in negative territory Tuesday morning in response to the announcement.
The post Accenture (ACN) and Google Cloud Launch AI Engineer Deployment Unit: Stock Analysis appeared first on Blockonomi.

Key Takeaways
Citi launched coverage of UiPath (PATH) with a Buy recommendation and $23 price objective
PATH shares tumbled 16% during the previous week, marking the worst weekly performance in four-plus months
Bank of America increased its price objective to $15 while maintaining an Underperform stance
Truist boosted its target to $17 and TD Cowen increased to $16, both keeping Hold recommendations
Second-quarter revenue climbed 13% to $410.26 million, surpassing consensus estimates of $397.8 million
UiPath (PATH) received a bullish endorsement from Citi analysts on Tuesday, as the investment bank launched coverage with a Buy recommendation and established a $23 price objective. This comes on the heels of a challenging period for the automation software company, whose shares plummeted 16% during the prior week—marking its most severe weekly decline in over four months.
Shares ticked up 0.2% in Tuesday’s premarket session. The stock is presently trading at a valuation premium compared to industry peers, as noted by Zacks, which assigns it a D grade on its Value Style Score metric.
Citi analyst Yitchuin Wang believes the post-earnings decline presents a compelling buying opportunity. Wang’s thesis centers on the notion that enterprise artificial intelligence will demand sophisticated orchestration spanning agents, models, human workers, APIs, and robotic process automation, with automation platforms remaining essential for governance and regulatory compliance frameworks.
Across Wall Street, firms have generally increased their price objectives following UiPath’s fiscal second-quarter financial disclosure, though these adjustments arrive accompanied by notable caution.
Street Ups Targets While Seeking AI Revenue Validation
Bank of America analyst Koji Ikeda elevated his price objective to $15 from a previous $13 while retaining an Underperform rating. Ikeda noted that the Q2 results failed to provide clarity on the critical question facing investors: whether artificial intelligence capabilities will meaningfully accelerate annual recurring revenue expansion. BofA did, however, modify its financial model to incorporate stronger profitability margin projections.
Truist Securities increased its price target to $17 from $12, maintaining a Hold rating on the shares. The firm acknowledges progress in agentic AI contract wins and modest customer base expansion, but emphasizes the need to observe accelerated growth metrics before adopting a more constructive stance.
TD Cowen lifted its price objective to $16 from $13, also preserving a Hold rating. The firm highlighted stable Q2 execution, solid customer retention metrics, and expanding AI adoption as encouraging signals.
DA Davidson analyst Lucky Schreiner raised his target to $16 from $12, remaining at Neutral. Schreiner observed that UiPath exceeded ARR projections and marginally elevated its fiscal 2027 ARR guidance.
Second Quarter Delivers Revenue Upside
UiPath’s second-quarter revenue reached $410.26 million, representing 13% year-over-year growth and exceeding the Street’s $397.8 million consensus forecast. Adjusted earnings per share came in at $0.15, matching analyst expectations. Gross margin contracted to 80% from 82% in the year-ago period.
Looking ahead, UiPath is projected to deliver $0.19 per share in earnings for the ongoing quarter, representing 18.8% year-over-year growth. The full fiscal year consensus estimate stands at $0.80 per share, reflecting 11.1% annual growth.
Zacks assigns PATH a #2 (Buy) ranking, citing consistent earnings estimate momentum despite the stock’s valuation premium relative to peers.
Revenue projections for the current quarter are pegged at $444.34 million, implying 8.1% year-over-year expansion.
UiPath has scheduled its investor day for September 22, where leadership is anticipated to present strategic initiatives designed to accelerate top-line growth.
The post UiPath (PATH) Stock Rebounds as Citi Analyst Spots Buying Opportunity Post-Selloff appeared first on Blockonomi.

Key Highlights
Amazon and Qualcomm revealed a partnership to develop specialized AI processors designed for hyperscale data center inference operations.
Amazon received a stock warrant from Qualcomm allowing purchase of up to 25 million shares priced at $161.26 per share.
The warrant agreement links to prospective revenues reaching $60 billion, with validity extending through September 2036.
Both tech giants are jointly developing advanced optical connectivity technology, featuring a cutting-edge 1.6T solution.
QCOM shares rallied up to 9.5% following the announcement, restoring year-to-date gains for 2026.
Shares of Qualcomm experienced a significant rally of up to 9.5% during Tuesday’s trading session following the announcement of a comprehensive chip development partnership with Amazon, delivering much-needed positive momentum for the semiconductor company.
The stock launched Tuesday’s session approximately 5.6% higher at the opening bell before momentum carried shares even higher. Prior to this announcement, QCOM had been underperforming relative to the wider semiconductor industry.
The partnership focuses on creating purpose-built AI processors tailored for Amazon’s expansive data center operations. These specialized chips will primarily handle inference tasks, where trained AI models process inputs and deliver results.
Amazon Web Services will collaborate closely with Qualcomm to engineer power-efficient processors optimized for large-scale AI workloads. Amazon contributes its infrastructure scale while Qualcomm leverages its extensive expertise in energy-efficient chip architecture.
QUALCOMM AND AMAZON PARTNER ON CUSTOM AI DATA CENTER CHIPS
Qualcomm $QCOM and Amazon have announced a multi-generational collaboration to develop customized silicon for AWS AI infrastructure, with an initial focus on large-scale AI inference.
The companies will also work on… pic.twitter.com/gMY7jOFZHE
— Wall St Engine (@wallstengine) September 8, 2026
The collaboration extends beyond processing power to encompass high-performance optical connectivity technologies. The companies are jointly engineering a next-generation 1.6T solution designed to transmit data at speeds reaching 1.6 terabits per second.
Qualcomm’s sophisticated SerDes and optical DSP platforms form the foundation of this connectivity initiative, designed to address the escalating bandwidth requirements of contemporary AI-driven data centers.
Understanding the Warrant Agreement
Under the terms of the arrangement, Qualcomm granted Amazon a warrant providing the right to acquire up to 25 million QCOM shares at an exercise price of $161.26 per share. This warrant remains exercisable until September 2036.
According to Qualcomm’s 8-K regulatory filing, the warrant structure correlates with potential revenues of up to $60 billion. This framework indicates a substantial long-term strategic alliance rather than a conventional short-term procurement arrangement.
Cristiano Amon, Qualcomm’s Chief Executive Officer, characterized the agreement as aligned with evolving AI infrastructure requirements. “As AI demand accelerates, data center infrastructure will require advances in both computing and connectivity to deliver greater performance with more efficiency,” he stated.
Prasad Kalyanaraman, AWS Vice President, emphasized that the partnership “builds on a strong foundation of partnership and reflects our shared commitment to pushing the boundaries of what’s possible.”
QCOM’s 2026 Market Performance
Prior to Tuesday’s rally, Qualcomm had been trailing the semiconductor sector throughout 2026. The PHLX Semiconductor Index has climbed 68% during the current year, while QCOM had remained in negative territory until this week’s announcement.
Following Tuesday’s surge, the stock has returned to positive performance for the year, although it continues to lag behind numerous semiconductor industry competitors.
The expanded agreement includes Qualcomm’s commitment to expand its utilization of AWS cloud infrastructure, incorporating Amazon Bedrock, to streamline chip development processes and reduce time-to-market cycles.
Amazon’s stock experienced a modest decline on Tuesday, falling less than 1% during the session.
QCOM shares were trading approximately 3.86% higher during Tuesday afternoon on September 8, 2026.
The post Qualcomm (QCOM) Stock Surges 9% on Massive $60B Amazon AI Partnership appeared first on Blockonomi.

Key Highlights
D-Wave Quantum (QBTS) shares climbed more than 4.5% Tuesday following confirmation of a $100M CHIPS Act funding package from the U.S. Department of Commerce.
The capital will finance construction of a 100,000-qubit annealing platform and a 10,000-qubit gate-model quantum computer.
The funding arrangement requires D-Wave to grant the federal government a minority, non-voting equity position in the company.
Technical indicators show continued weakness, with QBTS trading beneath both its 20-day and 200-day simple moving averages.
Wall Street analysts hold a Buy rating consensus with a mean price objective of $38.78.
Shares of D-Wave Quantum rallied over 4.5% Tuesday following the company’s announcement that it has executed a binding agreement with the U.S. Department of Commerce securing up to $100 million through the CHIPS and Science Act program. In premarket trading, the stock changed hands near $16.96, reflecting a 2.29% gain ahead of the opening bell.
While the financial commitment was previously outlined through a Letter of Intent, Tuesday’s disclosure officially solidified the arrangement between the quantum computing firm and federal authorities.
According to D-Wave, the allocated capital will finance research and development efforts across both its annealing and gate-model quantum computing platforms. This dual-technology approach distinguishes D-Wave from many competitors in the quantum sector.
The U.S. government is backing $RGTI and $QBTS with up to $200M combined to scale next generation quantum systems.
Commerce will also take minority stakes in both as Rigetti works to scale superconducting systems and D Wave targets up to 100,000 qubits. pic.twitter.com/mvzmm9x6x2
— Shay Boloor (@StockSavvyShay) September 8, 2026
The firm intends to deploy the resources toward constructing a 100,000-qubit annealing platform. Potential use cases span optimization challenges, materials modeling, blockchain applications, and artificial intelligence workloads.
Additionally, D-Wave is developing a 10,000-qubit gate-model architecture. This platform will be engineered to accommodate 100 logical qubits with the capability to execute over one million quantum operations, targeting quantum chemistry applications and quantum-enhanced AI.
Chief Executive Officer Alan Baratz praised the funding award, characterizing it as evidence of U.S. government commitment to quantum technology advancement. He noted the capital will enable D-Wave to broaden its domestic quantum infrastructure while reinforcing its supply chain operations.
Federal Equity Position Required
The funding comes with strings attached. Under the agreement terms, the U.S. Department of Commerce will acquire a minority, non-controlling ownership stake in D-Wave. Management positioned this arrangement as a mechanism to deliver potential financial upside to American taxpayers.
This transaction aligns with the overarching objectives of the CHIPS and Science Act, which seeks to expand domestic manufacturing and innovation capacity in cutting-edge technologies such as quantum computing.
Chart Analysis Reveals Weakness
The positive news notwithstanding, QBTS exhibits concerning technical characteristics. Shares currently trade 9.5% beneath the 20-day simple moving average of $18.81 and more than 20% under the 200-day SMA of $21.52.
The MACD indicator remains positioned below its signal line accompanied by a negative histogram reading. Furthermore, a death cross pattern materialized in March when the 50-day SMA dropped below the 200-day SMA, traditionally interpreted as a bearish technical development.
Market participants are monitoring $19.50 as a critical resistance threshold while $16 represents immediate support.
Nevertheless, Wall Street maintains optimistic expectations. Analysts assign a Buy consensus recommendation with a collective price target of $38.78. Rosenblatt preserved its Buy rating with a $43 price objective as of August, while Wedbush maintains an Outperform designation with a $40 target.
Investors seeking quantum computing exposure can access D-Wave through specialized exchange-traded funds including the WisdomTree Quantum Computing Fund (WQTM) and the Tradr 2X Long QBTS Daily ETF (QBTX).
The post D-Wave Quantum (QBTS) Gains 5% Following $100M CHIPS Act Award Finalization appeared first on Blockonomi.

Key Highlights
Rigetti Computing landed a $100M agreement with the U.S. Department of Commerce through the CHIPS Act
The capital will finance three research and development initiatives focused on superconducting quantum technology
Shares climbed approximately 6% during premarket hours, closing at $16.06 with a 5.66% gain
As part of the arrangement, the federal government will obtain a minority equity position without controlling interest
Analyst consensus shows six Buy ratings with a mean price objective of $32.60
On Tuesday, Rigetti Computing announced a $100 million financial commitment from the U.S. Department of Commerce, propelling RGTI shares upward by nearly 6% during premarket activity to reach $16.06.
The agreement was granted via the CHIPS Research and Development Office as part of the broader CHIPS Act initiative. The funding will facilitate three targeted research and development programs centered on superconducting quantum technology.
The three initiatives include: integrating readout electronics into a compact miniaturized format, enhancing cryogenic infrastructure through innovative cryostat design, and advancing manufacturing processes for high-connectivity quantum chip configurations.
Chief Executive Subodh Kulkarni stated that the financial backing will accelerate Rigetti’s progress toward practical, utility-scale quantum systems. “Addressing critical scalability obstacles provides us with the chance to revolutionize this sector,” Kulkarni noted.
Under the terms of the arrangement, the U.S. Department of Commerce will acquire a minority equity position in Rigetti without gaining controlling rights.
U.S. GOVERNMENT BACKS $RGTI & $QBTS WITH UP TO $200M FOR QUANTUM COMPUTING R&D
Rigetti has signed a definitive $100M agreement with the U.S. Department of Commerce to tackle key bottlenecks in scaling superconducting quantum systems, including cryogenics, readout electronics and… pic.twitter.com/ME2NSLR0Po
— Wall St Engine (@wallstengine) September 8, 2026
The capital injection aims to reduce both the timeline and expenses associated with constructing large-scale quantum platforms. According to Rigetti, this advancement will enable more widespread implementation and bolster the nation’s quantum computing infrastructure.
Challenging Technical Indicators Persist
Notwithstanding the recent price increase, RGTI’s technical analysis reveals ongoing challenges. Trading at $16.03, the equity was positioned 4.6% beneath its 20-day simple moving average and 2.4% under its 50-day simple moving average.
Additionally, the stock traded 12.4% below its 100-day simple moving average and 16.9% under its 200-day simple moving average. The MACD indicator continues to trend below its signal line, suggesting subdued momentum.
Market participants are monitoring $16.50 as immediate resistance and $15.50 as a key support threshold.
Wall Street Maintains Optimistic Outlook
Investment analysts continue to express confidence in RGTI’s prospects. Six analysts have established a consensus price objective of $32.60, representing approximately 100% upside from current levels.
Rosenblatt has reaffirmed its Buy recommendation alongside a $40 price target on two occasions this year, with the latest confirmation coming on August 7. Similarly, Wedbush reiterated an Outperform rating with a $40 target on August 3.
RGTI maintains significant representation in multiple quantum computing exchange-traded funds, including a 7.52% allocation in the Corgi Quantum Computing 2x Daily ETF (XQTM) and a 5.33% position in the WisdomTree Quantum Computing Fund (WQTM).
These substantial weightings indicate that capital flows into or out of these ETFs can substantially influence the stock’s price movement.
The funded programs will be carried out by Rigetti’s fully owned subsidiary, Rigetti & Co, LLC. The organization emphasizes that this work directly supports its strategic roadmap toward achieving commercially practical quantum computing solutions.
Kulkarni emphasized that lowering both expenses and construction timelines for scalable quantum platforms will provide broader accessibility for research institutions throughout the United States.
This CHIPS Act allocation represents among the most substantial federal investments in a dedicated quantum computing enterprise to date.
The post Rigetti Computing (RGTI) Stock Surges 6% on $100M Federal Quantum Deal appeared first on Blockonomi.

Key Takeaways
Investment bank Morgan Stanley has elevated Synopsys (SNPS) to Overweight from Equal-Weight, maintaining a $500 price objective.
The rating change reflects increased conviction around Ansys merger benefits and Design IP business stabilization.
Analysts highlight physical AI applications as a significant yet overlooked growth driver for the company’s solutions.
The semiconductor design software provider delivered fiscal Q3 2026 results exceeding forecasts with $3.91 non-GAAP EPS and $2.48 billion revenue.
Baird joined the bullish chorus by upgrading SNPS to Outperform with a $560 price objective.
Synopsys (SNPS) gained positive momentum this Tuesday after Morgan Stanley elevated its stance on the semiconductor design software company, shifting to Overweight from Equal-Weight while reaffirming a $500 price objective.
The rating revision came from analyst Lee Simpson, who positioned the move within Morgan Stanley’s strategic recalibration of semiconductor sector coverage. “As DRAM nears a late-cycle turning point and valuation gaps widen across the industry, we’re adopting a more discriminating approach,” Simpson explained in the research note.
At the time Morgan Stanley published its analysis, SNPS shares were changing hands near $393.84, reflecting a roughly 5.4% intraday decline that the firm characterized as a compelling buying opportunity amid recent share price softness.
Earlier in the year, the investment bank had shifted Synopsys to a neutral stance while monitoring three critical developments: margin expansion from the Ansys acquisition, renewed double-digit growth in electronic design automation, and validation of the strategic importance of its co-design capabilities.
According to Morgan Stanley, sufficient progress has now materialized across these metrics to justify returning to a positive investment recommendation.
Merger Benefits and Physical AI Applications
Central to Morgan Stanley’s investment case is progress on the Ansys merger. Synopsys unveiled Multiphysics Fusion during its third quarter, marking the inaugural combined offering from both organizations, and Morgan Stanley anticipates management will provide updated revenue synergy projections at the forthcoming investor event.
The research firm also contends that market participants are significantly undervaluing how strategically positioned Synopsys’ technology suite is for the physical AI revolution. Simpson specifically highlighted simulation capabilities addressing thermal management, structural integrity, and fluid flow analysis as especially valuable for bridging the simulation-to-reality divide.
The recently introduced Factory 2 IP framework, a tailored intellectual property solution designed for cloud giants and custom chip developers requiring specialized capabilities, represents another area Morgan Stanley expects the company to emphasize.
The semiconductor software provider has delivered 46% top-line expansion over the trailing twelve-month period while maintaining an 83% gross margin profile. Data from InvestingPro indicates the shares are currently valued below calculated fair value estimates.
Quarterly Results Exceed Forecasts and Additional Analyst Activity
The company’s fiscal third quarter 2026 financial performance surpassed Wall Street projections. Management reported non-GAAP earnings per share of $3.91, exceeding the Street consensus of $3.67, while revenue reached $2.48 billion compared to analyst estimates of $2.44 billion.
Following these results, Synopsys increased its full-year financial guidance. Benchmark maintained its positive rating, with analyst Gary Mobley characterizing the period as delivering a “beat-and-raise” performance.
In a separate action, Baird elevated Synopsys from Neutral to Outperform while increasing its price objective to $560. The firm pointed to encouraging growth prospects for fiscal year 2027 and anticipates a return to double-digit organic revenue expansion.
On the same day, Morgan Stanley downgraded Infineon (IFNNY) from Overweight to Equal-Weight, reducing its price target from €81 to €65. The bank also lowered targets on ASML to €1,700 from €1,930 and BE Semiconductor to €220 from €260.
Regarding Infineon, Simpson observed that “PSS projections appear elevated and multiple emerging headwinds leave us lacking a clear positive catalyst.”
Morgan Stanley’s $500 valuation target for SNPS represents no change from its prior price objective.
The post Morgan Stanley Upgrades Synopsys (SNPS) Stock to Overweight With $500 Price Target appeared first on Blockonomi.

Key Takeaways
Nebius has been designated as Palantir’s primary partner for sovereign AI infrastructure solutions.
Integration will embed Nebius computing and inference capabilities within Palantir’s enterprise infrastructure.
Enterprise customers gain sovereign control over compute resources, data storage, and AI models.
Joint efforts will accelerate AI capacity deployment, featuring modular data center implementations.
Nebius shares climbed 1.6% in premarket hours after the partnership reveal.
Nebius Group (NBIS) and Palantir Technologies (PLTR) have revealed a collaborative agreement that integrates Nebius’s AI-focused computing infrastructure within Palantir’s technology platform.
Shares of Nebius advanced 1.6% during premarket activity on September 8, 2026, following the partnership disclosure.
The agreement establishes Nebius as Palantir’s designated sovereign AI infrastructure partner of choice. Once integration is complete, Nebius’s computing and inference capabilities will operate within Palantir’s secure enterprise boundaries.
This arrangement enables qualified Palantir clients to utilize Nebius’s cloud computing and inference systems directly, maintaining complete oversight of their computational resources, proprietary data, and AI models while keeping sensitive operations within Palantir’s protected framework.
Palantir co-founder and CEO Alex Karp stated: “Nebius’ compute infrastructure powers your ability to run your own AI models under conditions you control. Our ontology and their infrastructure will undergird the sovereignty our partners are demanding.”
Nebius founder and CEO Arkady Volozh commented: “Organizations need both the performance of large-scale AI infrastructure and control over their data and models. Together with Palantir, we are bringing this to commercial clients enabling them to run their optimized open models on trusted infrastructure.”
Palantir delivers the software platform. Nebius contributes the computational backbone. This alliance combines both components into a unified solution for corporate customers.
Accelerated Infrastructure Deployment
Both organizations intend to collaborate on speeding up the timeline for bringing additional computing capacity online for Palantir’s client base.
This strategy encompasses modular data center installations at locations with existing power infrastructure, a pragmatic approach designed to shorten deployment cycles for delivering AI capabilities to customers.
For Nebius, this partnership creates an additional revenue stream for its expanding GPU infrastructure by tapping into Palantir’s established enterprise clientele.
Understanding Sovereign AI in This Context
Sovereign AI describes the capability for government entities and regulated enterprises to operate AI systems under rigorous geographical and security restrictions, ensuring sensitive information remains within designated jurisdictions.
Palantir has established its business model primarily around serving this particular client segment. Incorporating Nebius infrastructure expands computational resources available to these clients while maintaining stringent security parameters.
The collaboration is designed to allow Palantir to offer Nebius computing power without requiring clients to leave its platform ecosystem. Instead, the infrastructure is delivered directly within their existing environment.
Both organizations framed this alliance as addressing escalating demand from commercial customers seeking secure, high-performance AI capabilities while retaining full data sovereignty.
Nebius stock gained 1.6% in premarket trading on announcement day.
The post Palantir (PLTR) Selects Nebius (NBIS) as Primary Sovereign AI Infrastructure Provider appeared first on Blockonomi.

Key Takeaways
Wall Street firm Morgan Stanley slashed Peloton’s rating to Underweight from Equal-weight while reducing the price target from $5.50 to $4.50
New subscriber additions have plummeted approximately 78% from their peak levels, while connected fitness membership growth registered -9% year-over-year in fiscal year 2026
Lead analyst Nathan Feather characterized the challenges as structural rather than cyclical, attributing them to fundamental changes in consumer fitness preferences
Investment bank UBS reduced its price objective to $10.00 from $11.00 and lowered its fiscal 2027 EBITDA projection to $491 million from $526 million due to elevated subscriber attrition
Shares of PTON declined by as much as 6.1% during premarket hours, trading significantly beneath the 52-week peak of $9.20
Peloton stock plummeted up to 6.1% during Tuesday’s premarket session, touching $5.07, following Morgan Stanley’s decision to downgrade the shares to Underweight from Equal-weight while simultaneously cutting the price objective from $5.50 down to $4.50.
Nathan Feather, the analyst spearheading the call, cautioned that ongoing negative earnings revisions could prompt fundamental questions regarding the company’s long-term valuation prospects.
Feather’s primary alarm centers on the dramatic deterioration of Peloton’s subscriber acquisition pipeline. New customer additions have contracted by roughly 78% from peak levels, while the connected fitness subscriber base experienced -9% year-over-year contraction during fiscal 2026. Morgan Stanley’s projections anticipate this downward trajectory will persist through fiscal 2029 with negative compound annual growth rates.
The investment bank’s assessment leaves little room for optimism: these challenges represent permanent headwinds. Feather characterized the obstacles as structural in nature, stemming from fundamental transformations in consumer fitness behavior patterns.
Consumer Preferences Moving Beyond Peloton’s Model
Data from Google Search reveals that interest in strength training has expanded at an 8% compound annual growth rate throughout the previous decade, recently eclipsing cardio searches for the first time in history. Simultaneously, gym membership rates are climbing, with 24% of Americans now holding active memberships, representing an increase from 20% recorded in 2021.
This evolving landscape presents a fundamental threat to Peloton’s connected fitness platform and cycling-centric business approach.
Morgan Stanley wasn’t alone in reassessing Peloton on Tuesday. UBS preserved its Buy recommendation but reduced the price target from $11.00 to $10.00, while simultaneously lowering its fiscal 2027 EBITDA forecast from $526 million down to $491 million.
UBS pointed to subscriber churn rates exceeding expectations as the primary concern, indicating issues that extend beyond the one-time factors previously communicated by Peloton leadership.
The convergence of two negative analyst actions within a single premarket trading window delivered a distinctly bearish message to investors.
Executive Stock Sales Compound Negative Sentiment
Corporate insider activity patterns have further weighed on investor confidence. Half a dozen company executives offloaded shares throughout the previous three-month period, with zero recorded insider purchases during the same timeframe.
Broader equity markets provided minimal support for the struggling stock. The S&P 500 retreated 0.3% while the Dow Jones declined 0.8%, though the Nasdaq remained essentially unchanged. Peloton’s weakness stemmed from firm-specific issues rather than industry-wide pressures.
Short interest in PTON currently represents 14.4% of available shares, creating conditions for sustained downward momentum.
The current trading price sits far beneath the 52-week high of $9.20 and approaches the lower boundary of the annual range at $3.65. For historical perspective, Peloton reached its all-time closing peak of $167.42 on January 13, 2021.
Morgan Stanley’s revised $4.50 price target positions just marginally above the 52-week floor.
The post Peloton (PTON) Stock Plunges 6% After Morgan Stanley Downgrade on Subscriber Woes appeared first on Blockonomi.

Key Highlights
IonQ increased its 2026 annual revenue projection to $450M-$460M after completing the SkyWater Technology acquisition
Shares of IONQ climbed over 6% during premarket hours Tuesday, reaching $41.91
The company announced an $8.18M quantum security partnership with Congruity360 focused on enterprise data protection
New research from IonQ indicates a ~20,000-qubit quantum computer could potentially compromise Bitcoin encryption within 26 days
Wall Street analysts maintain a consensus Buy recommendation with a mean price target of $70
Tuesday proved eventful for IonQ. The quantum computing firm announced an upgraded revenue forecast, finalized a significant security partnership, and released notable Bitcoin-related research findings during a single trading session.
Shares of IONQ advanced 6.06% to $41.91 during premarket activity.
The quantum computing company now projects 2026 annual revenue between $450 million and $460 million. This updated range incorporates SkyWater’s revenue contribution spanning July 31 through the end of the year, following the acquisition’s closure.
The revised projection excludes anticipated intercompany transactions stemming from a pre-existing commercial arrangement between IonQ and SkyWater prior to the acquisition.
CEO and Chairman Niccolo de Masi stated the guidance “underscores both the commercial momentum of our quantum platform and the manufacturing capabilities delivered by SkyWater.” The company conducted its inaugural combined Investor Day webcast at 12:30 p.m. EDT on Tuesday.
According to IonQ, the firm is working on a unified technology roadmap alongside SkyWater. Management anticipates the merger will expedite progress toward commercially viable, fault-tolerant quantum computing systems.
Congruity360 Partnership Worth $8.18M
In a separate announcement, IonQ revealed an $8.18 million partnership with Congruity360 to implement quantum-resistant network solutions for corporate customers.
The agreement involves IonQ providing its Clavis quantum key distribution pairs alongside Solteris Network Appliances. Congruity360 will incorporate this technology into its data management infrastructure, supporting enterprises across finance, healthcare, insurance, legal services, manufacturing, defense, and higher education sectors.
This partnership comes after a June 2026 White House executive order that pushed federal post-quantum cybersecurity deadlines to 2030 while expanding these mandates to include government contractors.
IonQ characterizes this as among the most substantial commercial quantum security contracts disclosed domestically. The firm has prior experience implementing quantum-safe networks through collaborations with Florida LambdaRail and alongside Cisco in Switzerland.
Bitcoin Encryption Research Makes Headlines
IonQ simultaneously released research outlining how a fault-tolerant quantum computing system could theoretically break secp256k1, the cryptographic elliptic curve underlying Bitcoin’s security.
The projection: approximately 20,000 physical qubits would be necessary to accomplish this feat within roughly 26 days. IonQ emphasized this represents a theoretical resource calculation rather than an actual proof-of-concept.
According to the company, the hardware specifications described match systems anticipated on its development timeline around 2028.
From a technical perspective, IONQ is currently trading 0.4% above its 20-day simple moving average and 2.4% above its 50-day SMA. Conversely, it trades 11.7% below its 100-day SMA and 4.5% beneath its 200-day SMA. The relative strength index registers 46.31, indicating neutral momentum conditions.
Primary resistance emerges at $48, corresponding with the 100-day SMA level. Critical support is positioned near $40.
Eleven Wall Street analysts maintain a consensus Buy recommendation for IonQ stock. The mean price target stands at $70, with individual projections spanning $50 to $100. Benchmark reiterated its Buy rating with a $60 target, Needham sustained its Buy rating at $65, and Cantor Fitzgerald maintained an Overweight rating at $70.
The post IonQ (IONQ) Stock Climbs 7% on Quantum Security Contract and Revenue Upgrade appeared first on Blockonomi.

Key Points
Strategy recorded zero Bitcoin transactions last week following its first acquisition since June on August 31
Shares fell 3% to $138.43 during Tuesday’s premarket session
Strategy’s Bitcoin holdings total 845,050 BTC with an average acquisition cost of $75,412 per coin
Canaccord Genuity increased its MSTR price target to $179 while maintaining its “buy” recommendation
Bitcoin declined more than 1% over 24 hours, trading at $78,443
Strategy Inc. reported no Bitcoin buying or selling activity for the previous week in a Tuesday regulatory disclosure. This marks a pause following the company’s initial purchase since late June, when it acquired 4,603 Bitcoin during the period of August 24-30 for $369.7 million, representing an average cost of $80,318 per token.
Shares of MSTR fell 3% to $138.43 during premarket hours on Tuesday. The stock had previously finished Friday’s session down 1.4%.
The equity has climbed 73% from its recent bottom of $82.31 reached on June 26. However, year-to-date performance shows a 6% decline.
Strategy’s Bitcoin treasury currently stands at approximately 845,050 BTC, purchased at an average cost of roughly $75,412 per unit. This position establishes the firm as the world’s largest publicly traded corporate Bitcoin holder.
Bitcoin decreased over 1% during the previous 24-hour period to $78,443, based on CoinDesk data. Coinbase shares retreated 1.6%, whereas Robinhood advanced 1.8%.
Wall Street Perspective
Canaccord Genuity upgraded its price objective on MSTR from $175 to $179 on Tuesday while reaffirming its “buy” stance. This revised target suggests approximately 25% potential upside from present trading levels.
The overall Wall Street consensus registers as “Moderate Buy,” featuring an average price objective of $236.65. Among 20 tracked analysts, 14 assign a Buy rating, two recommend Strong Buy, two suggest Hold, and two rate it as Sell.
Bearish voices exist as well. TD Cowen reduced its target from $400 down to $260, while Barclays trimmed its objective from $130 to $125, although both firms preserved positive recommendations. Mizuho established a $165 target.
Financial Performance and Results
Strategy disclosed a per-share loss of $24.45 in its latest quarterly report, significantly exceeding the consensus forecast of a $2.19 loss. The company generated $122.37 million in revenue, representing a 6.9% year-over-year increase, falling marginally short of the $122.90 million analyst projection.
Strategy operates with a negative return on equity of 74.18% and a negative net margin exceeding 6,000%. Wall Street forecasts anticipate a full-year per-share loss of $23.74.
Regarding insider transactions, CEO Phong Le acquired 11,000 MSTR shares in June at $90.80 apiece. Director Jarrod Patten divested 2,775 shares in August at $125.33 each. Collectively, insiders sold 13,950 shares during the past 90 days. Insider ownership stands at approximately 6.49%, while institutional investors control 59.84%.
MSTR stock commenced Tuesday trading at $142.80, carrying a market capitalization of $54.87 billion. The 52-week trading range extends from $81.81 to $365.21.
The post Strategy (MSTR) Stock Slides 3% as Bitcoin Accumulation Halts and BTC Drops Under $79K appeared first on Blockonomi.

Key Takeaways
Tesla’s highly anticipated Cybercab made its Texas debut following an Austin launch event, but the unveiling failed to impress investors, resulting in a 5.9% stock decline and approximately $88 billion in erased market capitalization.
The National Highway Traffic Safety Administration has initiated an audit examining Tesla’s self-certification process for the Cybercab, which lacks traditional steering wheels and pedals, raising federal safety compliance questions.
August U.S. vehicle sales plummeted 26% year-over-year to 40,816 units, marking Tesla’s most severe monthly contraction in 2026. Chinese market sales also declined 12.4%.
Analyst opinions remain divided: GLJ Research’s Gordon Johnson maintains a Sell rating with a $24.86 target, while Canaccord Genuity’s George Ginarikas holds a Buy rating, describing the Cybercab as representing “tomorrow’s look.”
According to TipRanks, TSLA maintains a Moderate Buy consensus rating with an average analyst price target of $377.08, suggesting 6.5% potential upside. Year-to-date, shares have declined 21%.
Shares of Tesla were changing hands at $354.57 during Tuesday’s premarket session, posting a modest 0.1% gain, as the investment community continued digesting the implications of last week’s Cybercab introduction.
The autonomous Cybercab officially began operating in Texas after its September 3 unveiling in Austin. This revolutionary vehicle eliminates conventional steering wheels and foot pedals, operating exclusively through optical camera technology. Tesla’s camera-centric strategy potentially provides a significant cost advantage compared to competitors utilizing more expensive lidar and radar sensor configurations.
However, the launch event failed to generate expected enthusiasm. Shares tumbled 5.9% in the trading session following the presentation, obliterating approximately $88 billion in shareholder value. This decline came after a 5.4% rally leading up to the announcement.
GLJ Research analyst Gordon Johnson issued a scathing assessment. He highlighted that Tesla registered merely 45 vehicles, declined to disclose the actual number of operational Cybercabs, avoided livestreaming the event, kept CEO Elon Musk away from the presentation stage, and provided no pricing information, per-mile cost projections, or consumer ordering mechanism. Johnson maintains a Sell rating with a $24.86 price objective.
Wells Fargo analyst Colin Langan echoed the bearish sentiment, reaffirming his Sell rating with a $130 target. His analysis concluded that the reveal provided insufficient technical specifications and lacked a concrete deployment schedule to support current valuation levels.
Bullish perspectives exist, however. Canaccord Genuity’s George Ginarikas maintains a Buy rating and praised the Cybercab as “slick” and “luminous,” suggesting it embodies the futuristic vision Musk has consistently promoted. Nevertheless, he recognizes that achieving sufficient geographic service density will be critical for market acceptance.
Deteriorating Sales Figures Intensify Concerns
The Cybercab controversy unfolds amid challenging sales performance. Tesla reported estimated U.S. deliveries of 40,816 vehicles in August, representing a 26% decline from 55,500 units during the same period last year. This marks Tesla’s most significant year-over-year monthly contraction throughout 2026, surpassing the 20% decrease in June and 21% drop in July.
Chinese market performance proved similarly disappointing. Tesla delivered 50,047 vehicles in China during August, down 12.4% year-over-year, extending the decline to three consecutive months. The automaker has resorted to offering discounts reaching 10,000 yuan (approximately $1,475) on Model Y inventory units.
European results presented a fragmented picture. Registration data showed dramatic increases of 279% in France and 104% in Denmark. Conversely, significant decreases occurred across Norway, Spain, Sweden, Portugal, and Italy.
Regulatory Scrutiny Emerges
The National Highway Traffic Safety Administration has launched an audit investigating Tesla’s self-certification process declaring the Cybercab compliant with federal safety regulations. The agency’s examination centers on the vehicle’s operation without conventional steering mechanisms or pedals, a configuration that falls outside established federal motor vehicle safety framework.
This regulatory matter remains pending resolution.
Regarding financial performance, second-quarter revenue increased 26% year-over-year to $28.24 billion, though operating margin compressed to merely 1.4%.
According to TipRanks, TSLA carries a Moderate Buy consensus rating based on 11 Buy recommendations, 13 Hold ratings, and three Sell ratings, with analysts projecting an average price target of $377.08.
The post Tesla (TSLA) Stock Faces Headwinds as August Sales Plunge 26% and Cybercab Debut Falls Flat appeared first on Blockonomi.

Key Takeaways
Shares of LULU plummeted 17.4% in one trading session to $100.61, marking an 80% decline from the peak of $511.29 reached in late 2023
Second-quarter revenue declined 4% year-over-year to $2.4 billion, while physical store sales plunged 9%; earnings of $2.92 per share were boosted by a $134.5 million one-time tariff refund
Management slashed 2026 full-year revenue projections to $10.35 billion from the $11.35 billion forecast issued in March—the third downward revision this year
Company founder Chip Wilson initiated divorce proceedings without a prenuptial agreement, placing his 9.9 million share position valued near $1 billion under court jurisdiction
Analyst consensus assigns LULU a Hold rating, with a mean price target of $103.37 representing minimal 2.74% potential appreciation from current trading levels
Shares of Lululemon closed Monday’s trading session at $100.61, representing a steep 17.4% single-day decline. The athletic apparel retailer now trades approximately 80% beneath its all-time peak of $511.29 reached in December 2023.
The sharp downturn followed disappointing second-quarter financial results and the company’s third consecutive reduction to its full-year 2026 revenue forecast.
Second-quarter net sales totaled $2.4 billion, reflecting a 4% year-over-year contraction. Physical retail locations experienced a more pronounced 9% sales decline. The reported earnings figure of $2.92 per share benefited from a non-recurring $134.5 million refund related to tariffs, artificially inflating profitability metrics.
Stripping out this one-time windfall reveals a more challenging underlying business reality. Company leadership cited diminished consumer appetite, lackluster reception to recent product introductions, and intensifying competitive pressures across North American markets.
Revised Outlook Shakes Investor Confidence
Lululemon has revised its full-year 2026 net revenue expectations to a range of $10.35 billion to $10.50 billion. This represents a substantial retreat from the $11.35 billion projection communicated just months ago in March. The company’s adjusted EPS forecast of $9.48 to $9.73 incorporates $0.86 per share from tariff refunds and interest income already realized during the second quarter.
For the third quarter, management anticipates revenue will contract 10% to 11%, settling in a range between $2.29 billion and $2.32 billion.
Leadership is also scaling back the company’s temporary retail presence and exercising greater discretion regarding permanent store expansions. While this conservative approach may safeguard profit margins, it simultaneously caps growth potential should market conditions improve.
Soon-to-be CEO Heidi O’Neill inherits challenging market dynamics, particularly declining foot traffic at North American retail locations.
Divorce Proceedings Introduce Governance Questions
Adding complexity to the company’s operational challenges, court filings revealed that founder Chip Wilson and his spouse Shannon “Summer” Wilson have initiated divorce proceedings in British Columbia without any prenuptial protections in place.
The pair wed in 2002, five years prior to Lululemon’s 2007 initial public offering. British Columbia family law mandates equal division of marital assets accumulated during the marriage by default.
Chip Wilson and affiliated entities control 9.9 million shares, constituting an 8.7% voting interest in the company. Based on Friday’s closing price, this equity position carried a valuation approaching $1 billion. Summer Wilson already directly owns approximately 1.1 million of these shares.
The litigation effectively places a significant voting bloc under court supervision and confidentiality. This development arrives mere months after Chip Wilson secured two board positions at the company.
Current Wall Street consensus places LULU at a Hold rating, derived from zero Buy recommendations, 19 Hold ratings, and three Sell opinions. The consensus price target of $103.37 suggests limited upside of approximately 2.74% from the present price of $100.61.
Pessimistic analysts project revenue could decline to as little as $9.7 billion by 2029, significantly below the Street’s consensus expectation of $12.2 billion.
The post Lululemon (LULU) Stock Plummets 17% Following Earnings Shortfall and Founder’s Divorce Filing appeared first on Blockonomi.

Key Takeaways
Futures declined Tuesday morning as crude oil neared $100 per barrel, intensifying speculation about Federal Reserve policy tightening
Intel topped premarket gainers in the S&P 500, with AMD and Marvell following suit amid sustained AI semiconductor enthusiasm
Novartis plummeted 13% following failed clinical trial for muscle disorder treatment, triggering declines in Sarepta and Dyne Therapeutics
Roivant Sciences soared 20% on encouraging Phase 2 data from subsidiary’s lung disease therapy candidate
ASML gained 2% after major chipmakers validated commitment to adopting next-generation manufacturing equipment
Equity futures traded in negative territory Tuesday morning as Brent crude maintained levels above $98 per barrel. The escalating energy costs are amplifying market expectations for the Federal Reserve to implement additional rate increases during its upcoming policy meeting.
However, semiconductor stocks focused on artificial intelligence applications defied the broader market weakness during early trading hours. Intel emerged as the S&P 500’s leading performer in premarket activity, advancing 3.6%. Advanced Micro Devices and Marvell experienced similar upward momentum, accompanied by gains in Micron and Sandisk.
Semiconductor Sector Defies Market Headwinds
ASML contributed to the optimistic semiconductor narrative, climbing 2% after verification that Samsung, Taiwan Semiconductor Manufacturing, and Intel are proceeding with implementation strategies for its High-NA extreme ultraviolet lithography systems.
ASML’s Chief Technology Officer indicated that a proposed transition from 6-inch to 12-inch photomasks has potential to enhance machine productivity by as much as 40%. TSMC and ASML are working toward establishing a 12-inch mask testing facility by 2031, followed by full-scale commercial manufacturing by 2033.
Roivant Sciences captured the position of Tuesday’s strongest performer, skyrocketing 20%. Its subsidiary Pulmovant disclosed encouraging Phase 2 clinical data for mosliciguat, an experimental therapy targeting pulmonary hypertension associated with interstitial lung disease.
The investigational treatment achieved its primary efficacy measure, demonstrating approximately 56% reduction in pulmonary vascular resistance versus placebo. Additional benefits included improving six-minute walking capacity by roughly 35 meters and reducing a critical cardiac stress biomarker by 53%.
Pharmaceutical Stocks Retreat Following Novartis Disappointment
Novartis declined 13% after its late-phase clinical study evaluating muscle-wasting treatment del-desiran missed its primary efficacy target. This marked the pharmaceutical giant’s third consecutive clinical development failure within a single week.
$NVS shares are falling as much as 10% after Novartis’ del-desiran failed the pivotal Phase 3 HARBOR study in myotonic dystrophy type 1, missing its primary endpoint on muscle function.
It’s Novartis’ second major late-stage trial setback in a matter of days, following the… pic.twitter.com/xJhz2KwTRW
— Wall St Engine (@wallstengine) September 8, 2026
The clinical setback reverberated throughout the biotechnology sector. Dyne Therapeutics plunged 30%, Sarepta Therapeutics retreated 11%, and NewAmsterdam Pharma slipped 9%.
Novartis’s troubles also pressured Amgen, which declined nearly 5%. Amgen is advancing its own cardiovascular therapeutic candidate called olpasiran, prompting investor concern about similar developmental risks.
Novartis’s Chief Medical Officer characterized clinical setbacks as inherent components of pharmaceutical innovation. The organization maintained its projected 5% to 6% annual revenue expansion guidance extending through 2030.
Zim Integrated Shipping Services advanced 6% following announcements from Hapag-Lloyd and private equity partner FIMI that they would modify their proposed $4.2 billion takeover after consultations with Israeli authorities.
The transaction has encountered resistance within Israel from labor unions, defense establishment representatives, and government officials citing national security considerations. Hapag-Lloyd acknowledged ongoing collaboration with Israeli government stakeholders to implement structural adjustments to the acquisition framework.
Fuel-cell manufacturer Bloom Energy rose 5.9%, data infrastructure company Everpure increased 3%, and biotechnology firm Illumina ticked up 0.9%. All three companies are scheduled for S&P 500 inclusion on September 21.
Builders FirstSource, Molson Coors Beverage, and Trade Desk face removal from the S&P 500, and all three experienced declines on Tuesday.
The post Market Shake-Up: Intel (INTC) Surges on AI Demand as Novartis Drug Failure Hammers Biotech Sector appeared first on Blockonomi.

TLDR
Shares of Boston Scientific declined 2.3% in early trading following the company’s announcement that it will be unable to achieve Q3 and full-year 2026 targets.
The financial shortfall is directly attributed to the security breach that was initially identified on August 25.
Management had earlier projected annual sales expansion of 5.5% to 6.5% alongside adjusted earnings per share ranging from $3.28 to $3.32.
Year-to-date, BSX shares have declined 50%, with a 55% drop over the trailing twelve months, trading significantly below the 52-week peak of $109.50.
While TD Cowen maintained its Buy recommendation with a $56 target price, the formal financial alert overshadowed this optimistic stance.
Boston Scientific (BSX) shares retreated 2.3% to $46.68 during premarket hours on Tuesday following the medical device manufacturer’s official announcement that it will be unable to meet previously issued financial targets for the third quarter and full fiscal year 2026.
The revised outlook stems directly from the cybersecurity incident that the organization first revealed on August 25. In Tuesday’s regulatory disclosure, BSX stated it is “unlikely to meet” its projected revenue growth and adjusted earnings per share ranges for both the current quarter and the entire fiscal year.
This represents a more definitive position compared to the company’s earlier communications, when management indicated the financial consequences of the security breach remained undetermined.
Back in late July, Boston Scientific had established expectations for annual revenue expansion of 5.5% to 6.5% and adjusted earnings per share between $3.28 and $3.32. For the third quarter specifically, management projected revenue growth of 3% to 5% with adjusted earnings per share of 80 to 82 cents.
According to FactSet data, Wall Street analysts had been anticipating full-year adjusted earnings of $3.30 per share on revenue of $21.35 billion, with third-quarter consensus estimates at 81 cents per share and revenue of $5.26 billion.
The stock has experienced significant challenges throughout the year, even before this recent development. BSX has lost 50% of its value year-to-date and declined 55% over the past twelve months. Current trading levels sit far below the 52-week peak of $109.50, hovering closer to the 52-week bottom of $42.20.
Analyst Reactions
The withdrawal of financial guidance intensifies pressure on a stock already facing analyst concerns. Argus Research had earlier moved BSX from Buy to Hold, highlighting worries about expansion prospects for the Watchman product line and the domestic electrophysiology business segment.
Following second-quarter results and the initial cyber incident disclosure, Baird, JPMorgan, and Bank of America each reduced their price objectives for the stock.
TD Cowen stood out as the exception, maintaining its Buy rating alongside a $56 price target. The investment firm observed that by September 5, Boston Scientific’s primary distribution facilities were handling and dispatching products at or exceeding typical capacity levels. Despite this encouraging operational update, it provided minimal relief against Tuesday’s formal financial warning.
What Comes Next
Boston Scientific indicated it has discovered no signs of continued unauthorized system access, although the inquiry remains ongoing.
Management noted that it anticipates recapturing a portion of the foregone revenue as business operations normalize, customer orders get processed, and order backlogs diminish.
The complete financial toll from the security incident has yet to be quantified. Boston Scientific intends to provide comprehensive details regarding its operational status and financial trajectory, including the cyberattack’s consequences, when it reports third-quarter results on October 28.
Fellow medical technology companies Abbott and Medtronic have similarly confronted cybersecurity challenges in 2026, contributing to sustained caution across the broader sector.
The post Boston Scientific (BSX) Stock Tumbles as Cyberattack Forces Earnings Warning appeared first on Blockonomi.

TLDR
GE Aerospace announces the purchase of Consolidated Precision Products (CPP) for $11.75 billion, representing its largest transaction since splitting from General Electric.
CPP is valued at approximately 26x projected 2027 Ebitda without synergies, falling to 18x when factoring in anticipated cost efficiencies.
The transaction will be financed through a combination of cash reserves and debt financing, with first-year EPS accretion expected.
The acquisition follows Elon Musk’s recent comments identifying turbine blade casting capacity as a critical constraint for AI infrastructure expansion.
Shares of GE declined 0.6% during premarket hours following the deal announcement.
GE Aerospace (NYSE: GE) saw its shares decline 0.6% in early Tuesday trading following the announcement of an $11.75 billion acquisition of casting manufacturer Consolidated Precision Products.
This transaction represents the aviation company’s most significant acquisition since CEO Larry Culp orchestrated the historic division of General Electric into three independent entities: GE HealthCare Technologies, GE Vernova, and GE Aerospace.
The aerospace giant will finance the purchase through a combination of existing cash and new debt. Management anticipates the deal will enhance earnings per share within the first complete year following closure.
Based on CPP’s projected 2027 Ebitda, the acquisition price represents a multiple of approximately 26x before accounting for synergies. When anticipated cost savings are included, this valuation multiple decreases to roughly 18x. As a comparison point, Howmet Aerospace, another player in the casting space, currently commands an estimated 2027 Ebitda multiple of about 28x.
The announcement’s timing carries particular significance. Recently, Elon Musk indicated that SpaceX might pursue investments in turbine blade production to address what he characterized as a critical constraint for artificial intelligence infrastructure growth. His reasoning: AI data centers require substantial power, power generation depends on turbines, and turbines require precision-manufactured cast blades.
Musk’s statements ignited discussion about whether casting manufacturers now face potential competition from SpaceX, or whether his remarks merely validate projections of sustained high demand for casting capacity in coming years.
GE Bets on the Demand Side
GE Aerospace’s strategic decision indicates confidence that demand will exceed available supply. CPP produces blades for jet engines as well as power generation turbines. While GE Aerospace’s primary focus centers on jet engine applications across commercial and defense markets, the core casting technology has applications across both sectors.
The acquisition represents a vertical integration strategy, albeit an unconventional approach. CPP maintains relationships with third-party clients, and GE Aerospace has committed to preserving these external sales channels. The strategic objective centers on expanding total production capacity rather than limiting competitor access to supply.
Prior to Tuesday’s announcement, GE Aerospace shares had appreciated 9% during the current year and posted 21% gains over the trailing twelve months. Trading commenced at $336.66, within a 52-week trading range spanning $268.91 to $388.84. The company maintains a market capitalization near $349 billion with a price-to-earnings ratio of 39.65.
Wall Street Still Broadly Bullish
Analyst coverage remains predominantly favorable. Among 19 analysts providing coverage, 16 maintain Buy recommendations, two rate the stock as Hold, and one has assigned a Sell rating. The average price target stands at $390.59.
Recent analyst actions include Citigroup establishing a $431 price objective and JPMorgan elevating its target to $400 with an Overweight designation. Goldman Sachs maintained its Buy rating with a $410 target. Royal Bank of Canada increased its price target to $400 from a previous $355.
Regarding financial performance, GE Aerospace delivered Q2 earnings of $2.02 per share, surpassing the consensus forecast of $1.86. Quarterly revenue reached $12.63 billion, exceeding analyst expectations of $11.87 billion and representing a 21.1% year-over-year increase.
Management has established 2026 full-year EPS guidance in the range of $7.65 to $7.85, while the analyst consensus projection for the year stands at $7.91.
Institutional ownership of GE Aerospace stock represents 74.77% of shares outstanding. In recent insider activity, SVP Mohamed Ali divested 8,096 shares at $353.71 on July 24th, decreasing his direct holdings by 28.15%.
The post GE Aerospace (GE) Stock Dips Following $11.75B Acquisition of Casting Specialist CPP appeared first on Blockonomi.